malin, 4%/O paraformaldehyde, periodatelysine-paraformaldehyde (PLP) and periodate-lysine-paraformaldehydedichromate (PLPD) before embedding in paraffin wax for sectioning. Similar tissue blocks were snap frozen and cryostat sections were postfixed in these fixatives, either alone or in combination, before immunostaining. Results-In paraffin wax embedded sections the best fixative was PLP, and in frozen tissues the best results were obtained after fixation of cryostat sections in buffered formalin followed by cold methanol and acetone. Applying these fixatives to samples from a further 16 gastrectomy specimens, strong membrane staining of c-erbB-2 protein was found in the tumour in eight of 16 cases (50%) using paraffin wax sections, and staining was stronger in the better differentiated carcinomas. For frozen tissues, positive membrane staining was found in all gastric adenocarcinomas, but differential staining intensity associated with tumour differentiation could not be detected. Conclusions-These results indicate that fixation and paraffin wax embedding affect the results of immunohistochemical demonstration of c-erbB-2 in gastric cancer. The choice of fixative is critical in the demonstration and evaluation of c-erbB-2 protein expression by immunohistochemistry in gastric carcinomas. Staining results also vary depending on whether frozen or paraffin wax embedded tissues are studied.
(J Clin Pathol 1994;47:117-121)
The human proto-oncogene, c-erbB-2 (also called HER-2 and neu gene) encodes a cell surface glycoprotein that is similar in structure to the epidermal growth factor receptor (EGF-R),'-5 and has been mapped to band q21 of chromosome 17.6 It is the human analogue of the transforming gene neu, originally found in rat neuroblastoma cell lines derived from tumours induced by ethylnitrosourea.' The product/ of the c-erbB-2 gene is a 185 kilodalton transmembrane glycoprotein, with an extracellular ligand binding domain and an intracellular domain with tyrosine kinase activity, which is involved in signal transduction.
Because of these structural similarities to the EGF-R, it has been suggested that the cerbB-2 gene product may function as a receptor for some as yet unidentified growth factor. In normal tissues c-erbB-2 expression has been demonstrated predominantly in epithelial cells,7 but the physiological function of cerbB-2, like that of other known peptide growth factor receptors, has not been clarified. A possible role for the c-erbB-2 gene in the pathogenesis of human cancer has been implicated by its relatively frequent amplification in human carcinomas arising from breast,l'0 stomach," ovary,9 salivary gland,'2 kidney,'314 colon,'4 and lung. 5
Immunohistochemical staining of oncoproteins has been used as a semiquantitative and relatively simple method of assessing oncogene expression. The results reported by various authors are often conflicting. One possible explanation is the use of different fixation procedures by various workers. We therefore tested the effects of various fixatives on immunohistochemical staining intensity and cellular localisation of c-erbB-2 protein, using paraffin wax embedded and cryostat sections. After selecting an optimal fixative we compared the expression of c-erbB-2 in adenocarcinomas of the stomach with adjacent non-neoplastic stomach mucosal epithelium.
Methods

TISSUE PREPARATIONS
A total of 20 fresh gastrectomy specimens received in the Department of Pathology, University of Hong Kong, were studied; the specimens were all resections performed for Using the first four cases, the fixative that gave the highest sensitivity in paraffin wax sections compared with frozen sections, best membrane localisation, high signal to background ratio, and best preservation of morphology, was chosen for the detailed study of the remaining cases.
HISTOLOGICAL EVALUATIONS
The selected blocks were assessed histologically and the presence or absence of adenocarcinomatous tissue was confirmed. There were 10 cases of intestinal type (of which one was also mucinous), four cases of diffuse type (of which one was also mucinous), and two cases of mixed intestinal and diffuse type.
The carcinomatous tissue present in the in gastric and breast tissues or, as suggested by Falck et al, breast cancers in a positive tumour uniformly overexpress the c-erbB-2 proteins, while in gastric cancers, the expression can be patchy or very focal.'9
Previous studies by different investigators have shown discrepant results for the expression of c-erbB-2 oncoprotein in gastric tumours. Houldsworth et al, 20 Yonemura et al,2' Falck et al,'9 and Lemoine et al,22 using formalin fixed paraffin wax sections, showed that positive staining was found in 10%, 12%, 19%, and 26% of gastric carcinomas, respectively. This low level of positivity, compared with our results, indicates that using routine formalin fixed paraffin wax embedded material may underestimate the percentage of positivity in tumours studied. Southern blotting has shown c-erbB-2 amplification in 6-22% of gastric carcinomas in various studies (Park et al 23; Yokota et al 1113; Ranzani et al24). In another study, using western blotting, Kameda et al 5 reported that 55% of cases showed higher expression of c-erbB-2 protein in extracts of tumours compared with normal tissue. These studies support our finding that c-erbB-2 protein is frequently overexpressed in gastric cancer.
Focal to membrane staining was found in "normal" gastric epithelium in paraffin wax sections, even when the tumour was negative, but this staining pattern was not observed in frozen sections in our study.
Our results demonstrate that the sensitivity of immunostaining is dependent on fixation procedure and the detection of c-erbB-2 in 50% of our cases using PLP fixed paraffin wax sections is more in keeping with the finding by Kameda et al using western blotting.25 Using frozen sections, we not only detected the presence of c-erbB-2 in all 16 cases of gastric carcinomas, but we have also demonstrated the consistent enhanced expression of the oncoprotein in tumour tissues.
A higher prevalence of membrane staining was found in moderate to well differentiated carcinomas than in poorly differentiated adenocarcinoma in PLP fixed paraffin wax sections in our study. This is similar to the result reported by Jain et al. 26 There is no correlation, however, between the differentiation of the tumour and the intensity of staining in frozen sections, in contrast to the results using paraffin wax sections. This suggests that there may be a difference in resistance to loss of antigenicity of c-erbB-2 protein following fixation in tumours with a different degree of differentiation. The reason for this is not known and deserves further investigation.
We conclude that the choice of fixative is critical in the demonstration and evaluation of c-erbB-2 protein expression shown by immunohistochemistry in gastric carcinomas.
Staining results also vary, depending on whether frozen or paraffin wax embedded tissues are studied. Correlation of staining intensity with tumour differentiation is also influenced by such factors. This must be taken into consideration when collecting and comparing data. 
